Ardelyx (ARDX) Current Leases (2019 - 2026)
Ardelyx (ARDX) posted Current Leases of $1.5 million for Q1 2026, up 2.1% on a QoQ basis from $1.5 million in Q4 2025, and up 15.98% year-over-year from $1.3 million in Q1 2025.
Ardelyx (ARDX) Current Leases (2019 - 2026) Analysis & Trends
Ardelyx's Current Leases history runs 8 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- Quarterly Current Leases rose 15.98% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 15.98% YoY) and the FY2025 annual result came in at $1.5 million, down 5.31% from the prior year.
- Current Leases was $1.5 million for Q1 2026 at Ardelyx, up from $1.5 million in the prior quarter.
- Across five years, Current Leases topped out at $4.4 million in Q4 2023 and bottomed at $1.2 million in Q2 2025.
- A 5-year average of $3.0 million and a median of $3.6 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases surged 154.39% — and 2025, when it plunged 69.82%.
- Ardelyx's Current Leases stood at $3.9 million in 2022, then rose by 13.89% to $4.4 million in 2023, then plunged by 64.78% to $1.6 million in 2024, then declined by 5.31% to $1.5 million in 2025, then gained by 2.1% to $1.5 million in 2026.
- Business Quant data shows ARDX's Current Leases at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 1.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.44 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 2.57 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 4.44 Mn |
| Sep 30, 2023 | 4.32 Mn |
| Jun 30, 2023 | 4.11 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 3.89 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Jun 30, 2022 | 3.69 Mn |
| Mar 31, 2022 | 3.59 Mn |
| Dec 31, 2021 | 3.49 Mn |
| Sep 30, 2021 | 3.39 Mn |
| Jun 30, 2021 | 3.18 Mn |